Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -32.53% is 86% above its 4-year average of -239.63%, near the high end of its 4-year range (-352.86%–-32.53%).
As of the fiscal period ended Wednesday, December 31, 2025. 81.09% above its 12-month average of -171.99%.
Annual fiscal-year return on invested capital; no daily interpolation. Historical series through 2025-12-31.
RETURN ON INVESTED CAPITAL (ROIC)
-32.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-171.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-201.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-239.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+81.09%
CURRENT VS 3Y AVG
+83.89%
CURRENT VS 5Y AVG
+86.42%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.19%
median of 716 covered companies
CURRENT VS SECTOR MEDIAN
+1.97%
vs the sector median at left
NewcelX Ltd.
Market Cap
$1.33M
Return on Invested Capital (ROIC)
-32.53%
TTM Avg
-171.99%
3Y Avg
-201.88%
5Y Avg
-239.63%
Market Cap
$1.35M
Return on Invested Capital (ROIC)
-107.08%
TTM Avg
-750.62%
3Y Avg
-506.81%
5Y Avg
-355.90%
Market Cap
$1.41M
Return on Invested Capital (ROIC)
-219.36%
TTM Avg
-214.97%
3Y Avg
-160.97%
5Y Avg
-133.06%
Market Cap
$1.43M
Return on Invested Capital (ROIC)
-41.80%
TTM Avg
-42.68%
3Y Avg
-41.38%
5Y Avg
-63.25%
Market Cap
$1.24M
Return on Invested Capital (ROIC)
-709.40%
TTM Avg
-164.13%
3Y Avg
-164.13%
5Y Avg
-164.13%
Market Cap
$1.42M
Return on Invested Capital (ROIC)
-28.43%
TTM Avg
-37.81%
3Y Avg
-267.17%
5Y Avg
-197.37%
Market Cap
$1.46M
Return on Invested Capital (ROIC)
-163.98%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.18M
Return on Invested Capital (ROIC)
-183.49%
TTM Avg
-279.63%
3Y Avg
-279.63%
5Y Avg
-279.63%
Market Cap
$1.50M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-48.91%
3Y Avg
-66.07%
5Y Avg
-87.70%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewcelX Ltd. (NCEL) | $1.33M | -32.53% | -171.99% | -201.88% | -239.63% |
| Genprex, Inc. (GNPX)vs › | $1.35M | -107.08% | -750.62% | -506.81% | -355.90% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.41M | -219.36% | -214.97% | -160.97% | -133.06% |
| NEXGEL, Inc. (NXGL)vs › | $1.43M | -41.80% | -42.68% | -41.38% | -63.25% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.24M | -709.40% | -164.13% | -164.13% | -164.13% |
| INVO Fertility, Inc. (IVF)vs › | $1.42M | -28.43% | -37.81% | -267.17% | -197.37% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.46M | -163.98% | N/A | N/A | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.18M | -183.49% | -279.63% | -279.63% | -279.63% |
| PMGC Holdings Inc. (ELAB)vs › | $1.50M | N/A | -48.91% | -66.07% | -87.70% |
| Curis, Inc. (CRIS)vs › | $1.48M | -567.17% | -332.51% | -201.53% | -141.19% |
ROIC
-32.5%
ROE
-114.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -32.53% |
| 2024-12-31 | -311.45% |
| 2022-12-31 | -261.66% |
| 2021-12-31 | -352.86% |
| 2017-12-31 | -444.20% |
